A Really Good Day
Page 23
Acknowledgments
Thanks to Daniel Abrahamson, Peter Addy, Michelle Alexander, Julane Andries, Kristen Bearse, Paul Bogaards, Dr. Louann Brizendine, Sylvia Brownrigg, Sophie Chabon, Zeke Chabon, Ida-Rose Chabon, Abraham Chabon, Sean Cole, Amy Cray, Anna Dobben, Rick Doblin, Emma Dries, Clement (Clay) Dupuy, Dr. David Eagleman, Mary Evans, James Fadiman, Ian Faloona, Tim Ferriss, William Finnegan, Neill Franklin, Justine Frischmann, Madalyn Garcia, Peter Gasser, Mary Gaule, Ira Glass, August Gugelmann, Stephen Gutwillig, Daniel Handler, Zakiya Harris, Dr. Carl Hart, Jeff Holder, Dara Hyacinthe, Jennifer Jackson, Julia Kardon, Walter Kirn, Jenni Konner, Gregg Kulick, Alix Lambert, Yael Goldstein Love, Mabel, Larissa MacFarquhar, Dr. Shane MacKay, Maria Massey, Maighdlin Mau, Sonny Mehta, Dr. Michael Mithoefler, Ethan Nadelmann, Peggy Orenstein, Ann Packer, Kristi Panik, Danielle Plafsky, Michael Pollan, David Presti, Moriel Rothman-Zecher, Hans Ruge, Caissie St. Onge, George Sarlo, Nell Scovell, Ilena Silverman, Ann and Sasha Shulgin, Rebecca Skloot, Rebecca Solnit, Ed Swanson, Rebecca Traister, Gerald Valentine, Leonard Waldman, Ricki Waldman, Dr. Philip Wolfson, Amelia Zalcman, and Anne Zaroff-Evans.
And most of all, to Michael Chabon, who loves me, I know.
Bibliography
Alexander, Michelle. The New Jim Crow: Mass Incarceration in the Age of Colorblindness. New York: New Press, 2010.
Alper, Kenneth R., M.D., Howard S. Lotsof, Geerte M. N. Frenken, M.F.A., Daniel J. Luciano, M.D., and Jan Bastiaans, M.D. “Treatment of Acute Opioid Withdrawal with Ibogaine.” American Journal on Addictions 8 (1999): 234–42.
American College of Neuropsychopharmacology. “Active Ingredient in Magic Mushrooms Reduces Anxiety, Depression in Cancer Patients.” ScienceDaily, Dec. 10, 2015.
Ammerman, Seth, Sheryl Ryan, and William P. Adelman. “The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update.” Pediatrics 135, no. 3 (March 2015): e769–85. At doi: 10.1542/peds.2014-4147.
Amoroso, T., and M. Workman. “Treating Posttraumatic Stress Disorder with MDMA-assisted Psychotherapy: A Preliminary Meta-analysis and Comparison to Prolonged Exposure Therapy.” Journal of Psychopharmacology 30.7 (2016): 595–600.
Anderson, Pauline. “Scant Evidence for Long-Term Opioid Therapy in Chronic Pain.” Medscape, Jan. 13, 2015. At http://www.medscape.com/viewarticle/838056.
Annan, Kofi. “Why It’s Time to Legalize Drugs.” Huffington Post, Feb. 23, 2016. At http://www.huffingtonpost.com/kofi-annan/why-its-time-to-legalize-drugs_b_9298502.html.
Beck, Jerome, and Marsha Rosenbaum. Pursuit of Ecstasy: The MDMA Experience. Albany: State University of New York Press, 1994.
Bellum, Sara. “Real Teens Ask: How Many Teens Use Drugs?” NIDA for Teens, June 19, 2013. At https://teens.drugabuse.gov/blog/post/real-teens-ask-how-many-teens-use-drugs.
Bergamaschi, M. M., R. H. Queiroz, A. W. Zuardi, and J. A. Crippa. “Safety and Side Effects of Cannabidiol, a Cannabis Sativa Constituent.” National Center for Biotechnology Information. U.S. National Library of Medicine, Sept. 1, 2011. At http://www.ncbi.nlm.nih.gov/pubmed/22129319.
Bertram, Eva, Morris Blachman, Kenneth Sharpe, and Peter Andrea. Drug War Politics: The Price of Denial. Berkeley and Los Angeles: University of California Press, 1996.
Brown, David Jay, and Louise Reitman. “Psilocybin Studies and the Religious Experience: An Interview with Roland Griffiths, Ph.D.” MAPS Bulletin 20, no. 1, Dec. 18, 2009. At https://www.maps.org/news-letters/v20n1/v20n1-22to25.pdf.
Calderone, Julia. “The Rise of All-Purpose Antidepressants.” Scientific American, Nov. 1, 2014. At http://www.scientificamerican.com/article/the-rise-of-all-purpose-antidepressants/.
Carhart-Harris, R. L., M. Kaelen, M. Bolstridge, T. M. Williams, L. T. Williams, R. Underwood, A. Feilding, and D. J. Nutt. “The Paradoxical Psychological Effects of Lysergic Acid Diethylamide (LSD).” Psychological Medicine 46, no. 7 (2016): 1379–90. At doi: 10.1017/S0033291715002901.
Carhart-Harris, Robin L., Mark Bolstridge, James Rucker, Camilla M. J. Day, David Erritzoe, Mendel Kaelen, Michael Bloomfield, James A. Rickard, Ben Forbes, Amanda Feilding, David Taylor, Steve Pilling, Valerie H. Curran, and David J. Nutt. “Psilocybin with Psychological Support for Treatment-resistant Depression: An Open-label Feasibility Study.” The Lancet 3, no. 7 (July 2016): 619–27. At http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(16)30065-7/abstract.
Compton, Wilson, and Nora Volkow. “Major Increases in Opioid Analgesic Abuse in the United States: Concerns and Strategies.” Drug and Alcohol Dependence 81 (May 2005): 103–7.
Dass, Ram. Be Here Now. New York: Crown Publishing, 1971.
Dodes, Lance M., and Zachary Dodes. The Sober Truth: Debunking the Bad Science Behind 12-Step Programs and the Rehab Industry. Boston: Beacon Press, 2014.
Dyck, Erika. Psychedelic Psychiatry: LSD from Clinic to Campus. Baltimore: Johns Hopkins University Press, 2008.
Fadiman, James, Ph.D. The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys. Rochester, Vt.: Park Street Press, 2011.
Fish, Jefferson M., ed. How to Legalize Drugs. North Bergen, N.J.: Book-mart Press, 1998.
Gayomali, Chris. “Forget Coffee, Silicon Valley’s New Productivity Hack Is ‘Microdoses’ of LSD.” Gentlemen’s Quarterly, Nov. 23, 2015. At http://www.gq.com/story/forget-coffee-silicon-valleys-new-productivity-hack-is-microdoses-of-lsd.
Glatter, Robert, M.D. “LSD Microdosing: The New Job Enhancer in Silicon Valley and Beyond?” Forbes, Nov. 27, 2015. At http://www.forbes.com/sites/robertglatter/2015/11/27/lsd-microdosing-the-new-job-enhancer-in-silicon-valley-and-beyond/#3d455c9e114d.
Goldsmith, Neal M., Ph.D. Psychedelic Healing: The Promise of Entheogens for Psychotherapy and Spiritual Development. Rochester, Vt.: Healing Arts Press, 2011.
Gray, Mike. Drug Crazy: How We Got into This Mess and How We Can Get Out. New York: Random House, 1998.
Greenfield, Robert. Timothy Leary: A Biography. Orlando, Fla.: Harcourt, 2006.
Greenwald, Glenn. Drug Decriminalization in Portugal: Lessons for Creating Fair and Successful Drug Policies. Washington, D.C.: Cato Institute, 2009.
Grob, Charles S., Alicia L. Danforth, Gurpreet S. Chopra, Marycie Hagerty, Charles R. McKay, Adam L. Halberstadt, and George R. Greer. “Pilot Study of Psilocybin Treatment for Anxiety in Patients with Advanced-Stage Cancer.” Archives of General Psychiatry 68, no. 1 (2011): 71–78. At doi: 10.1001/archgenpsychiatry.2010.116.
Grof, Stanislav. Realms of the Human Unconscious: Observations from LSD Research. New York: Viking, 1975.
Gunten, Charles F. von. “The Pendulum Swings for Opioid Prescribing.” Journal of Palliative Medicine 19.4 (2016): 348.
Hagenbach, Leiter, and Lucius Wörthmüller. Mystic Chemist: The Life of Albert Hofmann and His Discovery of LSD. Trans. William Geuss and Linda Sperling. Santa Fe, N.M.: Synergetic Press, 2011.
Hart, Dr. Carl. High Price: A Neuroscientist’s Journey of Self-Discovery That Challenges Everything You Know About Drugs and Society. New York: HarperCollins, 2013.
Hart, Carl L., Joanne Csete, and Don Habibi. “Methamphetamine: Fact vs. Fiction and Lessons from the Crack Hysteria.” Open Society Institute, Feb. 2014. At https://www.opensocietyfoundations.org/publications/methamphetamine-dangers-exaggerated.
Hart, Carl L., Caroline B. Marvin, Rae Silver, and Edward E. Smith. “Is Cognitive Functioning Impaired in Methamphetamine Users? A Critical Review.” Neuropsychopharmacology 37, no. 3 (2011): 586–608. At http://www.ncbi.nlm.nih.gov/pubmed/22089317.
Hendricks, Peter S., Christopher B. Thorne, C. Brendan Clarke, David W. Coombs, and Matthew W. Johnson. “Classic Psychedelic Use Is Associated with Reduced Psychological Distress and Suicidality in the United States Adult Population.” Journal of Psychopharmacology 29, no. 3 (2015): 280–88. doi: 10.1177/0269881114565653.
Henry, Brook L., Arpi Minassian, and William Perry. “Effect of Methamphetamine Dependence on E
veryday Functional Ability.” Addictive Behaviors 35, no. 6 (2010): 593–98. At http://www.ncbi.nlm.nih.gov/pubmed/20167435.
Hintzen, Annelie, and Torsten Passie. The Pharmacology of LSD: A Critical Review. New York: Oxford University Press, 2010.
Hofmann, Albert, Ph.D. LSD, My Problem Child: Reflections on Sacred Drugs, Mysticism and Science. Trans. Jonathan Ott. Saline, Mich.: McNaughton & Gunn, 1983.
Holland, Julie, M.D. Moody Bitches. New York: Penguin, 2015.
Huxley, Aldous. The Doors of Perception and Heaven & Hell. New York: Thinking Ink, 2011.
Jamison, Kay Redfield. Touched with Fire. New York: Free Press Paperbacks, 1993.
———. An Unquiet Mind: A Memoir of Moods and Madness. New York: Random House, 1995.
Johnson, Matthew W., Albert Garcia-Romeu, Mary P. Cosimano, and Roland R. Griffiths. “Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction.” Journal of Psychopharmacology, Sept. 11, 2014. Last modified Oct. 16, 2014. At http://jop.sagepub.com/content/early/2014/09/06/0269881114548296.short.
Kaestner, Erik J., John T. Wixted, and Sara C. Mednick. “Pharmacologically Increasing Sleep Spindles Enhances Recognition for Negative and High-Arousal Memories.” Journal of Cognitive Neuroscience 25, no. 10 (2013): 1597–1610. At http://www.ncbi.nlm.nih.gov/pubmed/23767926.
Kirkpatrick, M. G., E. W. Gunderson, C. E. Johanson, F. R. Levin, R. W. Foltin, and C. L. Hart. “Comparison of Intranasal Methamphetamine and D-Amphetamine Self-Administration by Humans.” Addiction 107 (2012): 783–91.
Leonard, Andrew. “How LSD Microdosing Became the Hot New Business Trip.” Rolling Stone, Nov. 20, 2015.
Linnemann, T., and T. Wall. “ ‘This Is Your Face on Meth’: The Punitive Spectacle of ‘White Trash’ in the Rural War on Drugs.” Theoretical Criminology 17, no. 3 (2013): 315–34.
Markoff, John. What the Dormouse Said: How the 60s Counterculture Shaped the Personal Computer Industry. New York: Penguin, 2005.
Marks, John. The Search for the “Manchurian Candidate”: The CIA and Mind Control—The Secret History of the Behavioral Sciences. New York: Norton, 1991.
McKenna, Terence. Food of the Gods: The Search for the Original Tree of Knowledge: A Radical History of Plants, Drugs and Human Evolution. New York: Bantam Books, 1992.
Medina, K. L., K. L. Hanson, A. D. Schweinsburg, M. Cohen-Zion, B. J. Nagel, and S. F. Tapert. “Neuropsychological Functioning in Adolescent Marijuana Users: Subtle Deficits Detectable After a Month of Abstinence.” Journal of the International Neuropsychological Society 13, no. 5 (2007): 807–20. PMID no. 17697412.
Michaux, Henri. Miserable Miracle. Trans. Mary Jose Paz. New York: New York Review of Books, 2002.
Mithoefer, Michael C., Mark T. Wagner, Ann T. Mithoefer, Lisa Jerome, Scott F. Martin, Berra Yazar-Klosinski, Yvonne Michel, Timothy D. Brewerton, and Rick Doblin. “Durability of Improvement in Post-traumatic Stress Disorder Symptoms and Absence of Harmful Effects or Drug Dependency after 3,4-methylenedioxymethamphetamine-assisted Psychotherapy: A Prospective Long-term Follow-up Study.” Journal of Psychopharmacology (Oxford, England). SAGE Publications, Jan. 2013. At http://www.ncbi.nlm.nih.gov/pubmed/23172889.
Murakawa, Naomi. “Toothless.” Du Bois Review: Social Science Research on Race 8 (2011): 219–28. doi: 10.1017/S1742058X11000208.
Newline, Constance A. My Self and I. Toronto: Longman’s Canada, 1962.
O’Brien, Megan S., and James C. Anthony. “Extra-Medical Stimulant Dependence Among Recent Initiates.” Drug and Alcohol Dependence. U.S. National Library of Medicine, June 9, 2009. At http://www.sciencedirect.com/science/article/pii/S0376871609001574.
“Overdose Death Rates.” At drugabuse.gov. Last modified Dec. 2015.
Passie, Torsten, John H. Halpern, Dirk O. Stichtenoth, Hinderk M. Emrich, and Annelie Hintzen, “The Pharmacology of Lysergic Acid Diethylamide: A Review.” CNS: Neuroscience & Therapeutics 14 (2008): 295–314.
Pinchbeck, Daniel. Breaking Open the Head: A Psychedelic Journey into the Heart of Contemporary Shamanism. New York: Broadway Books, 2003.
Pollan, Michael. “The Trip Treatment.” New Yorker, Feb. 9, 2015.
Posner, Richard A. “We Need a Strong Prison System.” New Republic, July 31, 2016.
Presti, David E. Foundational Concepts in Neuroscience: A Brain-Mind Odyssey. New York: W.W. Norton, 2016.
Richards, William A. Sacred Knowledge: Psychedelics and Religious Experiences. New York: Columbia University Press, 2016.
Roberts, Thomas B., ed. Psychoactive Sacramentals: Essays on Entheogens and Religion. San Francisco: Council on Spiritual Practices, 2001.
Rosenbaum, Marsha. Safety First: A Reality-based Approach to Teens, Drugs, and Drug Education. San Francisco, Calif.: Safety First, 2004.
Rudd, Rose A., Noah Aleshire, Jon E. Ziebell, and R. Matthew Gladden. “Increases in Drug and Opioid Overdose Deaths—United States, 2000–2014.” CDC, Jan. 1, 2016. At http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6450a3.htm.
Schaler, Jeffrey A., Ph.D., ed. Drugs: Should We Legalize, Decriminalize or Deregulate? Amherst, N.Y.: Prometheus Books, 1998.
Sessa, Dr. Ben. The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society. London: Muswell Hill Press, 2012.
Sewell. R. A., J. H. Halpern, and H. G. Pope, Jr. “Response of Cluster Headache to Psilocybin and LSD.” Neurology, June 27, 2006. At http://www.ncbi.nlm.nih.gov/pubmed/16801660.
Shannon, Michael W., Stephen W. Borron, Michael J. Burns, Lester M. Haddad, and James F. Winchester. Haddad and Winchester’s Clinical Management of Poisoning and Drug Overdose. Philadelphia: Saunders/Elsevier, 2007.
Shroder, Tom. Acid Test: LSD, Ecstasy, and the Power to Heal. New York: Penguin, 2014.
Shulgin, Alexander, and Ann Shulgin. Pihkal: A Chemical Love Story. Berkeley, Calif.: Transform Press, 1991.
———. Tihkal: The Continuation. Berkeley, Calif.: Transform Press, 1997.
Siff, Stephen. Acid Hype: American News Media and the Psychedelic Experience. Urbana: University of Illinois Press, 2015.
Simon, Jonathan. Mass Incarceration on Trial: A Remarkable Court Decision and the Future of Prisons in America. New York: New Press, 2014.
Slater, Lauren. “How Psychedelic Drugs Can Help Patients Fake Death.” New York Times, April 20, 2012.
Squeglia, L. M., J. Jacobus, and S. F. Tapers, Ph.D. “The Influence of Substance Use on Adolescent Brain Development.” Clinical EEG and Neuroscience 40, no. 1 (2009): 31–38. doi: 10.1177/155005940904000110.
Strassman, Rick J. “Adverse Reactions to Psychedelic Drugs. A Review of the Literature.” The Journal of Nervous and Mental Disease 172.10 (1984): 577–95. At http://www.ncbi.nlm.nih.gov/pubmed/6384428.
Tagliazucchi, Enzo, Leor Roseman, Mendel Kaelen, Csaba Orban, Suresh D. Muthukumaraswamy, Kevin Murphy, Helmut Laufs, Robert Leech, John McGonigle, Nicolas Crossley, Edward Bullmore, Tim Williams, Mark Bolstridge, Amanda Feilding, David J. Nutt, and Robin Carhart-Harris. “Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution.” Current Biology, April 13, 2016. At http://dx.doi.org/10.1016/j.cub.2016.02.010.
Vollenweider, Franz X., and Michael Kometer. “The Neurobiology of Psychedelic Drugs: Implications for the Treatment of Mood Disorders.” Nature Reviews Neuroscience 11 (Sept. 2010): 642–51.
Weil, Andrew, M.D., and Winifred Rosen. From Chocolate to Morphine: Everything You Need to Know About Mind-Altering Drugs. New York: Houghton Mifflin, 1993.
Wodak, Dr. Alex, and Allie Cooney. “Effectiveness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS Among Injecting Drug Users.” World Health Organization, 2004. At http://www.who.int/hiv/pub/prev_care/effectivenesssterileneedle.pdf.
Wolfe, Tom. The Electric Kool-Aid Acid Test. New York: Picador, 1968.
Woolf, Virginia. A Room of One’s Own. San Diego: Harcourt, 1929.
A N
ote About the Author
Ayelet Waldman is the author of the novels Love and Treasure, Red Hook Road, Love and Other Impossible Pursuits, and Daughter’s Keeper, as well as of the essay collection Bad Mother: A Chronicle of Maternal Crimes, Minor Calamities, and Occasional Moments of Grace and the Mommy Track Mystery series. She coedited the Voice of Witness book Inside This Place, Not of It: Narratives from Women’s Prisons. Waldman was a federal public defender and taught at Loyola Law School and the UC Berkeley School of Law, where she developed a course on the legal and social implications of the war on drugs. She lives in Berkeley, California, with her husband and four children.
What’s next on
your reading list?
Discover your next
great read!
* * *
Get personalized book picks and up-to-date news about this author.
Sign up now.